|
1
|
Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle.
|
Nucleic Acids Res
|
2004
|
3.03
|
|
2
|
Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque.
|
Nat Med
|
2005
|
2.55
|
|
3
|
Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis.
|
Am J Pathol
|
2004
|
1.70
|
|
4
|
Harnessing in vivo siRNA delivery for drug discovery and therapeutic development.
|
Drug Discov Today
|
2006
|
1.32
|
|
5
|
In vivo application of RNA interference: from functional genomics to therapeutics.
|
Adv Genet
|
2005
|
1.30
|
|
6
|
Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis.
|
Arthritis Rheum
|
2005
|
1.04
|
|
7
|
Pharmaceutical prospects for RNA interference.
|
Pharm Res
|
2004
|
0.97
|
|
8
|
Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus.
|
Antivir Ther
|
2004
|
0.95
|
|
9
|
Modulation of angiogenesis with siRNA inhibitors for novel therapeutics.
|
Trends Mol Med
|
2005
|
0.94
|
|
10
|
Probing the mechanism of fusion in a two-dimensional computer simulation.
|
Biophys J
|
2002
|
0.88
|
|
11
|
Advances in Systemic siRNA Delivery.
|
Drugs Future
|
2009
|
0.87
|
|
12
|
siRNA-mediated antitumorigenesis for drug target validation and therapeutics.
|
Curr Opin Mol Ther
|
2003
|
0.87
|
|
13
|
Cryptococcus and Trichosporon spp. are susceptible in vitro to branched histidine- and lysine-rich peptides (BHKPs).
|
J Antimicrob Chemother
|
2011
|
0.82
|
|
14
|
Transporting silence: design of carriers for siRNA to angiogenic endothelium.
|
J Control Release
|
2005
|
0.82
|
|
15
|
Delivering small interfering RNA for novel therapeutics.
|
Methods Mol Biol
|
2008
|
0.79
|
|
16
|
Enhancement of antifungal activity by integrin-targeting of branched histidine rich peptides.
|
J Drug Target
|
2014
|
0.78
|
|
17
|
Increased tumor distribution and expression of histidine-rich plasmid polyplexes.
|
J Gene Med
|
2014
|
0.78
|
|
18
|
Buffering capacity and size of siRNA polyplexes influence cytokine levels.
|
Mol Ther
|
2012
|
0.78
|
|
19
|
Polymers for drug delivery: the debate continues.
|
Drug Discov Today
|
2003
|
0.75
|